Enterobacteriaceae
beta-Lactamases
Microbial Sensitivity Tests
beta-Lactam Resistance
Enterobacter
Serratia
Proteus
Carbapenems
Klebsiella
Escherichia
Klebsiella pneumoniae
beta-Lactams
Cephalosporins
Gram-Negative Bacteria
Citrobacter
Bacteria
Escherichia coli
Drug Resistance, Bacterial
Drug Resistance, Multiple, Bacterial
Drug Resistance, Microbial
Salmonella
Enterobacter cloacae
Serratia marcescens
Gram-Negative Bacterial Infections
Vibrionaceae
Evaluation Studies as Topic
Aztreonam
Ceftazidime
Proteus mirabilis
Klebsiella oxytoca
Shigella
Culture Media
Kluyvera
Pseudomonadaceae
Citrobacter freundii
Feces
Pseudomonas aeruginosa
Penicillanic Acid
Thienamycins
Azabicyclo Compounds
Conjugation, Genetic
Quinolones
Plasmids
Imipenem
Erwinia
Anti-Infective Agents
Clavulanic Acid
Aminoglycosides
Amikacin
Bacteremia
Acinetobacter
Piperacillin
Sequence Analysis, DNA
Kanamycin
Minocycline
Gene Transfer, Horizontal
Disk Diffusion Antimicrobial Tests
Gentamicins
Integrons
Species Specificity
Yersinia
Chromogenic Compounds
Polymerase Chain Reaction
Agar
Bacterial Typing Techniques
Fermentation
Molecular Sequence Data
Molecular Typing
Electrophoresis, Gel, Pulsed-Field
Pseudomonas
Cefoperazone
Proteus vulgaris
Multilocus Sequence Typing
Aeromonas
Ceftizoxime
Salmonella typhimurium
Carbenicillin
Urinary Tract Infections
RNA, Ribosomal, 16S
Colony Count, Microbial
Sulbactam
Hafnia alvei
Food Microbiology
Enterobacter aerogenes
Lactams
Monobactams
Norfloxacin
Penicillins
R Factors
Gram-Negative Aerobic Bacteria
Gastrointestinal Tract
Clavulanic Acids
Hospitals, University
Intraabdominal Infections
Fleroxacin
Ampicillin
Sisomicin
Cefmenoxime
Reagent Strips
Carrier State
Central African Republic
Pyronine
Molecular Epidemiology
Trimethoprim
Reagent Kits, Diagnostic
Moxalactam
Blood
Nalidixic Acid
Staphylococcus
Cephamycins
Isoelectric Focusing
DNA Fingerprinting
Cefamandole
Sensitivity and Specificity
Urine
Community-Acquired Infections
UK-18892, a new aminoglycoside: an in vitro study. (1/3467)
UK-18892 is a new aminoglycoside antibiotic, a derivative of kanamycin A structurally related to amikacin. It was found to be active against a wide range of pathogenic bacteria, including many gentamicin-resistant strains. The spectrum and degree of activity of UK-18892 were similar to those of amikacin, and differences were relatively minor. UK-18892 was about twice as active as amikacin against gentamicin-susceptible strains of Pseudomonas aeruginosa. Both amikacin and UK-18892 were equally active against gentamicin-resistant strains of P. aeruginosa. There were no appreciable differences in the activity of UK-18892 and amikacin against Enterobacteriaceae and Staphylococcus aureus. Cross-resistance between these two antimicrobials was also apparent. (+info)Ciprofloxacin decreases the rate of ethanol elimination in humans. (2/3467)
BACKGROUND: Extrahepatic ethanol metabolism is postulated to take place via microbial oxidation in the colon, mediated by aerobic and facultative anaerobic bacteria. AIMS: To evaluate the role of microbial ethanol oxidation in the total elimination rate of ethanol in humans by reducing gut flora with ciprofloxacin. METHODS: Ethanol was administered intravenously at the beginning and end of a one week period to eight male volunteers. Between ethanol doses volunteers received 750 mg ciprofloxacin twice daily. RESULTS: A highly significant (p=0.001) reduction in the ethanol elimination rate (EER) was detected after ciprofloxacin medication. Mean (SEM) EER was 107.0 (5.3) and 96.9 (4.8) mg/kg/h before and after ciprofloxacin, respectively. Faecal Enterobacteriaceae and Enterococcus sp. were totally absent after medication, and faecal acetaldehyde production capacity was significantly (p<0.05) decreased from 0.91 (0.15) to 0.39 (0.08) nmol/min/mg protein. Mean faecal alcohol dehydrogenase (ADH) activity was significantly (p<0. 05) decreased after medication, but ciprofloxacin did not inhibit human hepatic ADH activity in vitro. CONCLUSIONS: Ciprofloxacin treatment decreased the ethanol elimination rate by 9.4%, with a concomitant decrease in intestinal aerobic and facultative anaerobic bacteria, faecal ADH activity, and acetaldehyde production. As ciprofloxacin has no effect on liver blood flow, hepatic ADH activity, or cytochrome CYP2E1 activity, these effects are probably caused by the reduction in intestinal flora. (+info)Sodalis gen. nov. and Sodalis glossinidius sp. nov., a microaerophilic secondary endosymbiont of the tsetse fly Glossina morsitans morsitans. (3/3467)
A secondary intracellular symbiotic bacterium was isolated from the haemolymph of the tsetse fly Glossina morsitans morsitans and cultured in Aedes albopictus cell line C6/36. Pure-culture isolation of this bacterium was achieved through the use of solid-phase culture under a microaerobic atmosphere. After isolation of strain M1T, a range of tests was performed to determine the phenotypic properties of this bacterium. Considering the results of these tests, along with the phylogenetic position of this micro-organism, it is proposed that this intracellular symbiont from G. m. morsitans should be classified in a new genus Sodalis gen. nov., as Sodalis glossinidius gen. nov., sp. nov. Strain M1T is the type strain for this new species. (+info)High turnover rate of Escherichia coli strains in the intestinal flora of infants in Pakistan. (4/3467)
The Escherichia coli flora of infants in developed countries is dominated by one or a few strains which persist for prolonged periods of time, but no longitudinal studies have been performed in developing countries. To this end, we studied the rectal enterobacterial flora in 22 home-delivered Pakistani infants during their first 6 months of life. Three colonies were isolated and species typed on each of 11 sampling occasions. E. coli isolates were strain typed using electromorphic typing of cytoplasmic enzymes, and their O serogroups were determined. There was a very rapid turnover of enterobacterial strains in the rectal flora of individual infants. On average, 8.5 different E. coli strains were found per infant, and several biotypes of other enterobacteria. Less than 50% of the infants were colonized with E. coli from their mothers, but strains of maternal origin were four times more likely to persists in the infants' flora than other E. coli strains. Enterobacteria other than E. coli were always of non-maternal origin, and Enterobacter cloacae and Klebsiella pneumoniae biotypes recovered from contaminated feeds were later identified in the infants' rectal flora. An early colonization with klebsiella or enterobacter was significantly associated with diarrhoea during the neonatal period, although these bacteria were not likely to be the cause of the disease. The results suggest that poor hygienic conditions result in an unstable and diverse enterobacterial flora, which may influence infant health. (+info)The influence of a diet rich in wheat fibre on the human faecal flora. (5/3467)
The effect on the faecal flora of adding wheat fibre to a controlled diet in four healthy volunteers for a 3-week period has been observed. No change in the concentration of the bacteria in the bacterial groups counted was found, although there was a slight increase in total output associated with increased faecal weight. The predominant organisms in all subjects were non-sporing anaerobes, but the dominant species in each subject was different and was unaffected by changing the diet. Similarly, the concentration of faecal beta-glucuronidase detected in two subjects was unaltered and the concentration of clostridia able to dehydrogenate the steroid nucleus found in one subject was unaltered. It is suggested that the faecal microflora is not primarily controlled by the presence of undigested food residues in the large bowel. (+info)Use of an isogenic Escherichia coli panel to design tests for discrimination of beta-lactamase functional groups of Enterobacteriaceae. (6/3467)
A study was designed to determine if an isogenic panel of Escherichia coli strains containing many different beta-lactamases could be used for the preliminary screening of a large number of beta-lactam agents to identify which might be most useful in the development of a definitive test for specific beta-lactamases found among the members of family Enterobacteriaceae. The susceptibilities of 46 strains, comprising the isogenic panel, to expanded-spectrum cephalosporins, cephamycins, and aztreonam were determined in the presence and absence of beta-lactamase inhibitors in broth microdilution tests. The results indicated that strains producing extended-spectrum beta-lactamases (ESBLs) could be distinguished from strains producing other Bush-Jacoby-Medeiros functional group 2 or group 1 beta-lactamases. For strains producing group 1 beta-lactamases, cefpodoxime and ceftazidime MICs were > or = 4 micrograms/ml and addition of clavulanate did not reduce the MICs more than fourfold. For strains producing group 2 enzymes other than ESBLs, cefpodoxime and ceftazidime MICs were < or = 2 micrograms/ml. With a single exception (ceftazidime for the strain producing SHV-3), among strains producing ESBLs, cefpodoxime and ceftazidime MICs were > or = 4 micrograms/ml and addition of clavulanate reduced the MICs by more than eightfold. Cephamycins could also be used to discriminate between strains producing group 1 beta-lactamases and ESBLs, since only the former required cefotetan concentrations as high as 8 micrograms/ml or cefoxitin concentrations of > 16 micrograms/ml for inhibition. Other cephalosporins provided some discrimination between the various beta-lactamase producers, although they were not as reliable as either cefpodoxime or ceftazidime. These results indicate the utility of an isogenic panel for identification of candidate drugs among many for further testing with clinical isolates of the family Enterobacteriaceae to determine the best agents for detection of specific beta-lactamases in this family. (+info)Many class I integrons comprise distinct stable structures occurring in different species of Enterobacteriaceae isolated from widespread geographic regions in Europe. (7/3467)
Three sizes of inserted regions of DNA (800, 1,000, and 1,500 bp) were shown to be common among class I integrons in unrelated clinical isolates of Enterobacteriaceae from different European hospitals. Sequencing showed that 800-bp inserted regions comprised identical sequences including aacA4, that 1,000-bp inserted regions included aadA, and that 1,500-bp inserted regions included dfrI and aadA1, irrespective of host species and geographic origin. In addition promoter sequences were mostly identical for each size class. These data suggest that inserted gene cassettes and promoter regions of integrons are conserved and stable, with resistance genes transferred more often as part of the entire integron structure than as individual gene cassettes. (+info)Functional importance and local environments of the cysteines in the tetracycline resistance protein encoded by plasmid pBR322. (8/3467)
The properties of the cysteines in the pBR322-encoded tetracycline resistance protein have been examined. Cysteines are important but not essential for tetracycline transport activity. None of the cysteines reacted with biotin maleimide, suggesting that they are shielded from the aqueous phase or reside in a negatively charged local environment. (+info)Previous article'Etiology' Next article 'Esophageal Cancer'
Klebsiella Infections can occur in anyone, but certain groups of people are at higher risk, such as premature infants, people with weakened immune systems, and those with chronic medical conditions like diabetes, liver or kidney disease.
Symptoms of Klebsiella Infections include fever, chills, cough, difficulty breathing, painful urination, redness and swelling in the affected area, and in severe cases, sepsis and death.
Diagnosis of Klebsiella Infections is typically made through a combination of physical examination, medical history, and laboratory tests, such as blood cultures and urine cultures.
Treatment of Klebsiella Infections usually involves antibiotics, which can help clear the infection and prevent it from spreading. In severe cases, hospitalization may be necessary to provide appropriate care and monitoring.
Prevention of Klebsiella Infections includes good hand hygiene, proper cleaning and disinfection of equipment and surfaces, and avoiding close contact with individuals who have the infection. Vaccines are also available for certain types of Klebsiella Infections, such as pneumonia.
Complications of Klebsiella Infections can include pneumonia, urinary tract infections, bloodstream infections, and sepsis, which can lead to organ failure and death if left untreated.
Recovery from Klebsiella Infections usually occurs within a few days to a week after antibiotic treatment is started, but in severe cases, recovery may take longer and may require hospitalization and close monitoring.
In conclusion, Klebsiella Infections are a type of bacterial infection that can affect various parts of the body, and can be mild or severe. Prompt diagnosis and treatment with antibiotics are essential to prevent complications and ensure a successful recovery. Proper hygiene practices and vaccines are also important for preventing the spread of these infections.
Gram-negative bacterial infections can be difficult to treat because these bacteria are resistant to many antibiotics. In addition, some gram-negative bacteria produce enzymes called beta-lactamases, which break down the penicillin ring of many antibiotics, making them ineffective against the infection.
Some common types of gram-negative bacterial infections include:
* Pneumonia
* Urinary tract infections (UTIs)
* Bloodstream infections (sepsis)
* Meningitis
* Skin and soft tissue infections
* Respiratory infections, such as bronchitis and sinusitis
Examples of gram-negative bacteria that can cause infection include:
* Escherichia coli (E. coli)
* Klebsiella pneumoniae
* Pseudomonas aeruginosa
* Acinetobacter baumannii
* Proteus mirabilis
Gram-negative bacterial infections can be diagnosed through a variety of tests, including blood cultures, urine cultures, and tissue samples. Treatment typically involves the use of broad-spectrum antibiotics, such as carbapenems or cephalosporins, which are effective against many types of gram-negative bacteria. In some cases, the infection may require hospitalization and intensive care to manage complications such as sepsis or organ failure.
Prevention of gram-negative bacterial infections includes good hand hygiene, proper use of personal protective equipment (PPE), and appropriate use of antibiotics. In healthcare settings, infection control measures such as sterilization and disinfection of equipment, and isolation precautions for patients with known gram-negative bacterial infections can help prevent the spread of these infections.
Overall, gram-negative bacterial infections are a significant public health concern, and proper diagnosis and treatment are essential to prevent complications and reduce the risk of transmission.
In medicine, cross-infection refers to the transmission of an infectious agent from one individual or source to another, often through direct contact or indirect exposure. This type of transmission can occur in various settings, such as hospitals, clinics, and long-term care facilities, where patients with compromised immune systems are more susceptible to infection.
Cross-infection can occur through a variety of means, including:
1. Person-to-person contact: Direct contact with an infected individual, such as touching, hugging, or shaking hands.
2. Contaminated surfaces and objects: Touching contaminated surfaces or objects that have been touched by an infected individual, such as doorknobs, furniture, or medical equipment.
3. Airborne transmission: Inhaling droplets or aerosolized particles that contain the infectious agent, such as during coughing or sneezing.
4. Contaminated food and water: Consuming food or drinks that have been handled by an infected individual or contaminated with the infectious agent.
5. Insect vectors: Mosquitoes, ticks, or other insects can transmit infections through their bites.
Cross-infection is a significant concern in healthcare settings, as it can lead to outbreaks of nosocomial infections (infections acquired in hospitals) and can spread rapidly among patients, healthcare workers, and visitors. To prevent cross-infection, healthcare providers use strict infection control measures, such as wearing personal protective equipment (PPE), thoroughly cleaning and disinfecting surfaces, and implementing isolation precautions for infected individuals.
In summary, cross-infection refers to the transmission of an infectious agent from one individual or source to another, often through direct contact or indirect exposure in healthcare settings. Preventing cross-infection is essential to maintaining a safe and healthy environment for patients, healthcare workers, and visitors.
Some common examples of bacterial infections include:
1. Urinary tract infections (UTIs)
2. Respiratory infections such as pneumonia and bronchitis
3. Skin infections such as cellulitis and abscesses
4. Bone and joint infections such as osteomyelitis
5. Infected wounds or burns
6. Sexually transmitted infections (STIs) such as chlamydia and gonorrhea
7. Food poisoning caused by bacteria such as salmonella and E. coli.
In severe cases, bacterial infections can lead to life-threatening complications such as sepsis or blood poisoning. It is important to seek medical attention if symptoms persist or worsen over time. Proper diagnosis and treatment can help prevent these complications and ensure a full recovery.
Bacteremia can occur when bacteria enter the bloodstream through various means, such as:
* Infected wounds or surgical sites
* Injecting drug use
* Skin infections
* Respiratory tract infections
* Urinary tract infections
* Endocarditis (infection of the heart valves)
The symptoms of bacteremia can vary depending on the type of bacteria and the severity of the infection. Some common symptoms include:
* Fever
* Chills
* Headache
* Muscle aches
* Weakness
* Confusion
* Shortness of breath
Bacteremia is diagnosed by blood cultures, which involve collecting blood samples and inserting them into a specialized container to grow the bacteria. Treatment typically involves antibiotics and supportive care, such as intravenous fluids and oxygen therapy. In severe cases, hospitalization may be necessary to monitor and treat the infection.
Prevention measures for bacteremia include:
* Practicing good hygiene, such as washing hands regularly
* Avoiding sharing personal items like toothbrushes or razors
* Properly cleaning and covering wounds
* Getting vaccinated against infections that can lead to bacteremia
* Following proper sterilization techniques during medical procedures
Overall, bacteremia is a serious condition that requires prompt medical attention to prevent complications and ensure effective treatment.
Here are some common types of E. coli infections:
1. Urinary tract infections (UTIs): E. coli is a leading cause of UTIs, which occur when bacteria enter the urinary tract and cause inflammation. Symptoms include frequent urination, burning during urination, and cloudy or strong-smelling urine.
2. Diarrheal infections: E. coli can cause diarrhea, abdominal cramps, and fever if consumed through contaminated food or water. In severe cases, this type of infection can lead to dehydration and even death, particularly in young children and the elderly.
3. Septicemia (bloodstream infections): If E. coli bacteria enter the bloodstream, they can cause septicemia, a life-threatening condition that requires immediate medical attention. Symptoms include fever, chills, rapid heart rate, and low blood pressure.
4. Meningitis: In rare cases, E. coli infections can spread to the meninges, the protective membranes covering the brain and spinal cord, causing meningitis. This is a serious condition that requires prompt treatment with antibiotics and supportive care.
5. Hemolytic-uremic syndrome (HUS): E. coli infections can sometimes cause HUS, a condition where the bacteria destroy red blood cells, leading to anemia, kidney failure, and other complications. HUS is most common in young children and can be fatal if not treated promptly.
Preventing E. coli infections primarily involves practicing good hygiene, such as washing hands regularly, especially after using the bathroom or before handling food. It's also essential to cook meat thoroughly, especially ground beef, to avoid cross-contamination with other foods. Avoiding unpasteurized dairy products and drinking contaminated water can also help prevent E. coli infections.
If you suspect an E. coli infection, seek medical attention immediately. Your healthcare provider may perform a urine test or a stool culture to confirm the diagnosis and determine the appropriate treatment. In mild cases, symptoms may resolve on their own within a few days, but antibiotics may be necessary for more severe infections. It's essential to stay hydrated and follow your healthcare provider's recommendations to ensure a full recovery.
Symptoms of a UTI can include:
* Painful urination
* Frequent urination
* Cloudy or strong-smelling urine
* Blood in the urine
* Pelvic pain in women
* Rectal pain in men
If you suspect that you have a UTI, it is important to seek medical attention as soon as possible. UTIs can lead to more serious complications if left untreated, such as kidney damage or sepsis.
Treatment for a UTI typically involves antibiotics to clear the infection. It is important to complete the full course of treatment to ensure that the infection is completely cleared. Drinking plenty of water and taking over-the-counter pain relievers may also help alleviate symptoms.
Preventive measures for UTIs include:
* Practicing good hygiene, such as wiping from front to back and washing hands after using the bathroom
* Urinating when you feel the need, rather than holding it in
* Avoiding certain foods that may irritate the bladder, such as spicy or acidic foods
* Drinking plenty of water to help flush bacteria out of the urinary tract.
Intra-abdominal infections can be caused by a variety of microorganisms, including bacteria such as Escherichia coli, Klebsiella, and Staphylococcus aureus, and fungi such as Candida. The infection can spread to the abdominal cavity through various means, such as direct extension from an adjacent infected site, hematogenous spread (through the bloodstream), or contamination during surgery or other medical procedures.
The symptoms of intra-abdominal infections can vary depending on the location and severity of the infection, but may include fever, abdominal pain, nausea, vomiting, and diarrhea. In severe cases, the infection can lead to life-threatening complications such as sepsis (a systemic inflammatory response to infection) and organ failure.
Diagnosis of intra-abdominal infections typically involves a combination of physical examination, laboratory tests (such as blood cultures and abdominal imaging studies), and surgical exploration. Treatment usually involves antibiotics and/or surgical drainage of the infected site, and may also involve supportive care such as fluid replacement and management of complications.
Some common types of intra-abdominal infections include:
* Peritonitis: inflammation of the peritoneum, often caused by bacterial infection.
* Abscesses: pockets of pus that form in the abdominal cavity as a result of infection.
* Gastrointestinal (GI) infections: infections of the GI tract, such as appendicitis and diverticulitis.
* Urinary tract infections (UTIs): infections of the urinary system that can spread to the abdominal cavity.
Other names for intra-abdominal infections include:
* Abdominal infections
* Intra-abdominal sepsis
* Peritoneal infections
* Gastrointestinal infections
It is important to seek medical attention if you suspect that you or someone else may have an intra-abdominal infection, as prompt treatment can help prevent serious complications and improve outcomes.
Examples of CAIs include:
1. Respiratory infections such as bronchitis, pneumonia, and influenza.
2. Skin and soft tissue infections such as cellulitis, abscesses, and wound infections.
3. Gastrointestinal infections such as food poisoning, diarrhea, and gastroenteritis.
4. Urinary tract infections (UTIs) caused by bacteria that enter the urinary tract through the urethra or bladder.
5. Sexually transmitted infections (STIs) such as chlamydia, gonorrhea, and syphilis.
6. Bacterial infections such as staphylococcus aureus, streptococcus pneumoniae, and haemophilus influenzae.
7. Viral infections such as herpes simplex virus (HSV), human papillomavirus (HPV), and norovirus.
CAIs can be treated with antibiotics, antivirals, or other medications depending on the cause of the infection. It's important to seek medical attention if symptoms persist or worsen over time, as untreated CAIs can lead to serious complications and potentially life-threatening conditions.
Enterobacteriaceae
Carbapenem-resistant enterobacteriaceae
Soft rot Enterobacteriaceae (SRE) small RNAs
Pantoea
Pantoea stewartii
Drosophila suzukii
Serratia
Shigella dysenteriae
Gentamicin
Anaerobic infection
Oxidase test
Bacillary dysentery
Surgical mesh
Cronobacter sakazakii
Charles Arthur Stuart
Cedecea
AlgC RNA motif
Plasmid partition system
Enterobacter cloacae
Bacillus
Cholecystitis
Blochmannia
Biostraticola
Mesophile
Kerry LaPlante
Klebsiella pneumoniae
Faropenem
Vibriocin
Cefepime
Providencia (bacterium)
Carbapenem-Resistant Enterobacteriaceae: New Precautions
New carbapenem-resistant Enterobacteriaceae warrant additional action by healthcare providers
Browsing by Subject "Enterobacteriaceae"
Taxonomy browser (Enterobacteriaceae bacterium CC8I1)
Taxonomy browser (Enterobacteriaceae bacterium HRRK081)
Resistance mechanisms in Enterobacteriaceae - PubMed
New carbapenem-resistant Enterobacteriaceae warrant additional action by healthcare providers
Figure - Pretransplant Fecal Carriage of Extended-Spectrum β-Lactamase-producing Enterobacteriaceae and Infection after Liver...
Molecular epidemiology of integron-associated antibiotic resistance genes in clinical isolates of enterobacteriaceae - PubMed
Organism group: unclassified Enterobacteriaceae
Results from the Canadian Nosocomial Infection Surveillance Program on Carbapenemase-Producing Enterobacteriaceae, 2010 to 2014...
Comparison of methods for AmpC β-lactamase detection in Enterobacteriaceae
Dissemination in Portugal of CTX-M-15-, OXA-1-, and TEM-1-producing Enterobacteriaceae strains containing the aac(6')-Ib-cr...
WHO EMRO | CTX-M-15 extended-spectrum β-lactamases in Enterobacteriaceae in the intensive care unit of Tlemcen Hospital,...
ESBL (Extended spectrum beta-lactamase producing Enterobacteriaceae
Enterobacteriaceae Infections | Harvard Catalyst Profiles | Harvard Catalyst
CRACKLE: Carbapenems in Klebsiella pneumoniae and Other Enterobacteriaceae | J. Craig Venter Institute
Asymptomatic carriage of carbapenem-resistant Enterobacteriaceae 'considerable' | PM360
Duration of Carbapenemase-Producing Enterobacteriaceae Carriage in Hospital Patients - Volume 26, Number 9-September 2020 -...
Carbapenem-resistant Enterobacteriaceae Testing Market Projections Highlighting Primary Trends until | UKPRWire
New carbapenem-resistant Enterobacteriaceae warrant additional action by healthcare providers
Prevalence and Significance of Staphylococcus aureus and Enterobacteriaceae species in Selected Dairy Products and Handlers
Phenotypic and genotypic correlation of carbapenememase-producing Enterobacteriaceae and problems experienced in routine...
DISSERTATIONS.SE: Novel diagnostic methods for rapid characterization of extended-spectrum beta-lactamase- and carbapenemase...
Subjects: Enterobacteriaceae - Digital Collections - National Library of Medicine Search Results
Construction of stable fluorescent laboratory control strains for several food safety relevant Enterobacteriaceae. - PacBio
Controlling intestinal colonization of high-risk haematology patients with ESBL-producing Enterobacteriaceae: a randomized,...
Antimicrobial Resistance Threats | NIH: National Institute of Allergy and Infectious Diseases
Isolates9
- DeathsAttributabletoCRE Enterobacteriaceae with susceptible isolates) were excluded, as were studies Statistical Analysis that compared patients who had carbapenem-resistant in- We calculated pooled risk ratios (RRs) and 95% CIs fections with patients who were not infected. (cdc.gov)
- Enterobacterial repetitive intergenic consensus sequence type 2 PCR patterns of pairs of Escherichia coli isolates from 6 patients examined during study of extended-spectrum β-lactamase-producing Enterobacteriaceae infection among liver transplant recipients, France, January 2001-April 2010. (cdc.gov)
- ABSTRACT The aim of this study was to detect extended-spectrum β-lactamases (ESBL) in Enterobacteriaceae isolates in the intensive care unit (ICU) of Tlemcen hospital in north-western Algeria. (who.int)
- In all, 28 Enterobacteriaceae isolates were isolated from specimens recovered from patients in the ICU and 2 from surfaces of the unit. (who.int)
- In this study, we molecularly characterized 12 NDM-1 producing clinical Enterobacteriaceae ( Klebsiella pneumoniae, Escherichia coli, Enterobacter cloacae ) isolates that were part of a collection of non-carbapenem susceptible isolates obtained during a one-year period. (who.int)
- Teo J, Ngan G, Balm M, Jureen R, Krishnan P, Lin R. Molecular characterization of NDM-1 producing Enterobacteriaceae isolates in Singapore hospitals. (who.int)
- Methods From November 2011 to April 2012, 71 laboratories recorded non-duplicate Enterobacteriaceae clinical isolates NS to at least one carbapenem and the total number of isolates of the different species. (elsevier.com)
- Results During the study period, the 71 laboratories identified 133 244 Enterobacteriaceae isolates, of which 846 (0.63%) were NS to at least one carbapenem. (elsevier.com)
- on behalf of ONERBA's Carbapenem Resistance Study Group 2014, ' Incidence rates of carbapenemase-producing Enterobacteriaceae clinical isolates in France: A prospective nationwide study in 2011-12 ', Journal of Antimicrobial Chemotherapy , vol. 69, no. 10, pp. 2706-2712. (elsevier.com)
Infections9
- Enterobacteriaceae are responsible for a large proportion of serious, life-threatening infections and resistance to multiple antibiotics in these organisms is an increasing global public health problem. (nih.gov)
- Enterobacteriaceae Infections" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings) . (harvard.edu)
- Infections with bacteria of the family ENTEROBACTERIACEAE. (harvard.edu)
- This graph shows the total number of publications written about "Enterobacteriaceae Infections" by people in Harvard Catalyst Profiles by year, and whether "Enterobacteriaceae Infections" was a major or minor topic of these publication. (harvard.edu)
- Below are the most recent publications written about "Enterobacteriaceae Infections" by people in Profiles. (harvard.edu)
- A few infections caused by carbapenem-resistant Enterobacteriaceae outside the bowel include wound infection, urinary tract infection (UTI) and pneumonia. (ukprwire.com)
- Enterobacteriaceae , such as Klebsiella pneumoniae and Escherichia coli ( E. coli ) can cause serious infections of the urinary tract, bloodstream and wounds, and can also cause pneumonia. (nih.gov)
- Background: Pediatric bloodstream infections (BSIs) with Extended-Spectrum Beta-Lactamase- producing Enterobacteriaceae (ESBL-PE) are associated with worse clinical outcomes. (houstonmethodist.org)
- Ming DK, Otter JA, Ghani R, Brannigan ET, Boonyasiri A, Mookerjee S, Gilchrist M, Holmes AH, Davies F. Clinical risk stratification and antibiotic management of NDM and OXA-48 carbapenemase-producing Enterobacteriaceae bloodstream infections in the UK. (uams.edu)
Centers for Diseas2
- Citing increased reports of carbapenem-resistant Enterobacteriaceae (CRE), the Centers for Disease Control and Prevention (CDC) has expanded guidelines aimed at preventing the spread of these difficult-to-treat, multidrug-resistant organisms. (medscape.com)
- According to The Centers for Disease Control and Prevention (CDC), by 2013 Carbapenem-resistant enterobacteriaceae was found in almost 42 states. (ukprwire.com)
Klebsiella2
- The Consortium on Resistance Against Carbapenems in Klebsiella and other Enterobacteriaceae (CRACKLE) is a federally funded, prospective multi-center consortium to track carbapenem-resistant Enterobacteriacea . (jcvi.org)
- Klebsiella pneumoniae and Escherichia coli are two of the most clinically important pathogens of the family Enterobacteriaceae. (dissertations.se)
ESBL2
- The prevalence of extended-spectrum β-lactamase- (ESBL) producing Enterobacteriaceae (EPE) and carbapenemase-producing Enterobacteriaceae (CPE) are increasing worldwide. (dissertations.se)
- Some Enterobacteriaceae contain an enzyme called extended-spectrum β-lactamase (ESBL) which makes them resistant to nearly all penicillins and cephalosporins. (nih.gov)
Plasmid2
Carbapenems2
- Other Enterobacteriaceae can be resistant to carbapenems, which are considered drugs of last resort. (nih.gov)
- Objectives To determine proportions and incidence rates of Enterobacteriaceae producing carbapenemase among those non-susceptible (NS) to carbapenems in France. (elsevier.com)
Dissemination1
- Rapid global dissemination of carbapenemase-producing Enterobacteriaceae (CPE) poses a public health threat ( 1 ). (cdc.gov)
Acinetobacter1
- Producing Enterobacteriaceae and OXA-23-Producing Acinetobacter baumannii Sequence Type 2 in Tunisian Seafood. (bvsalud.org)
Agar2
- Carbapenem-resistant enterobacteriaceae testing includes disc diffusion or automated systems, selective agar Carbapenem-resistant enterobacteriaceae testing, minimal inhibitory concentration (MIC) for Carbapenem-resistant enterobacteriaceae testing, synergy Carbapenem-resistant enterobacteriaceae testing, modified Hodge tests, whole genome sequencing, spectrometrics and various other molecular methods. (ukprwire.com)
- All samples were examined for presence of Staphylococcus aureus (on Baird Parker agar medium) and Enterobacteriaceae sp. (scialert.net)
Prevalence1
- The prevalence and significance of Staphylococcus aureus and Enterobacteriaceae species in Ras cheese, Kareish cheese and ice cream samples and in swabs of dairy handlers in Ismailia city were studied. (scialert.net)
Resistance3
- Mutations in chromosomal genes contribute to antibiotic resistance, but Enterobacteriaceae are adapted to sharing genetic material and much important resistance is due to 'mobile' resistance genes. (nih.gov)
- This study compared the sensitivity and specificity of phenotypic methods of Bla(AmpC) detection in a collection of 246 Enterobacteriaceae with a diverse range of β-lactam resistance profiles. (nih.gov)
- Growing awareness about prevention of Carbapenem resistance and increased efforts by governments through the implementation of infection prevention and control measures might hinder the growth of the Carbapenem-resistant enterobacteriaceae testing market during the forecast period. (ukprwire.com)
Endemic2
- We evaluated the number of deaths attributable to care facilities around the world ( 6 - 13 ), and in some plac- carbapenem-resistant Enterobacteriaceae by using studies es, CRE have become endemic ( 14 - 18 ). (cdc.gov)
- Healthy travellers to countries where carbapenemases-producing Enterobacteriaceae (CPE) are endemic might be at risk for their acquisition, even without contact with the local healthcare system. (pasteur.fr)
Extended-spectrum1
- Appearance of aac(6')-Ib-cr gene among extended-spectrum beta-lactamase-producing Enterobacteriaceae in a French hospital. (nih.gov)
Strains2
- We performed a systematic search in the PubMed arbapenem-resistant strains have emerged among spe- (http://www.ncbi.nlm.nih.gov/pubmed/) and Scopus cies belonging to the Enterobacteriaceae family ( 1 , 2 ). (cdc.gov)
- Construction of stable fluorescent laboratory control strains for several food safety relevant Enterobacteriaceae. (pacb.com)
Search1
- Results of search for 'su:{Enterobacteriaceae. (who.int)
Isolation1
- Isolation demand from carbapenemase-producing Enterobacteriaceae screening strategies based on a West London hospital network. (uams.edu)
Urinary2
- Increase in the number of people requiring inpatient medical assistance, growing number of healthcare facilities, increased number of complex surgeries, multiple use of several antibiotics and rise in use of medical devices in the body, such as urinary catheters, intravenous catheters and ventilators, are few of the major factors responsible for growth in the Carbapenem-resistant enterobacteriaceae testing market. (ukprwire.com)
- Enterobacteriaceae -related disease usually occurs in patients at healthcare facilities who have weak immune systems, are on breathing machines or use urinary or intravenous catheters. (nih.gov)
Abstract1
- abstract = "We compared the Rodac imprint technique to selective enrichment broth for detecting vancomycin-resistant enterococci (VRE) and multidrug-resistant Enterobacteriaceae (MDRE) on surfaces. (northwestern.edu)
Carriage1
- To determine the duration of carbapenemase-producing Enterobacteriaceae (CPE) carriage, we studied 21 CPE carriers for »1 year. (cdc.gov)
Carbapenem10
- Carbapenem-resistant Enterobacteriaceae (CRE) are a major concern for patients in healthcare facilities. (cdc.gov)
- New Carbapenem-Resistant Enterobacteriaceae Warrant Additional Action by Healthcare Providers. (medscape.com)
- Cite this: Carbapenem-Resistant Enterobacteriaceae: New Precautions - Medscape - Feb 19, 2013. (medscape.com)
- These are called Carbapenem-resistant Enterobacteriaceae. (ukprwire.com)
- Carbapenem-resistant Enterobacteriaceae Testing Market is considered to be a gram-negative pathogen testing. (ukprwire.com)
- People prone to Carbapenem-resistant enterobacteriaceae include people admitted to hospitals or other healthcare settings. (ukprwire.com)
- People admitted to any healthcare setting for medical care are more prone to infection and to go for Carbapenem-resistant enterobacteriaceae testing than healthy people. (ukprwire.com)
- In Carbapenem-resistant Enterobacteriaceae Testing, Modified Hodge tests are anticipated to be one of the leading test types for Carbapenem-resistant enterobacteriaceae testing because of high accuracy of test results. (ukprwire.com)
- These tests are easy to perform and can be performed in a routine laboratory, which makes them more feasible and thus, one of the leading test types in Carbapenem-resistant enterobacteriaceae testing market. (ukprwire.com)
- Healthcare settings, such as nursing homes and acute care centers, where constant medical care is required for a longer duration of time are more prone to CRE and thus, the demand for Carbapenem-resistant enterobacteriaceae testing is higher in these settings. (ukprwire.com)
Detect1
- Evaluating serial screening cultures to detect carbapenemase-producing Enterobacteriaceae following hospital admission. (uams.edu)
Family1
- Enterobacteriaceae are a family of germs that most commonly live in a person's bowel without causing any disease. (ukprwire.com)
People1
- However, some people can have Enterobacteriaceae in their body without it causing any disease. (nih.gov)
Navigation1
- fr]En cliquant sur « Accepter tous les cookies », vous acceptez le stockage de cookies sur votre appareil pour améliorer la navigation sur le site, analyser son utilisation et contribuer à nos efforts de marketing pour soutenir la recherche. (pasteur.fr)